Serum neurofilament light chain levels correlate strongly with cognitive status in patients with relapsing and progressive multiple sclerosis

被引:0
|
作者
Edwards, K. [1 ]
Kamath, A. [1 ]
O'Connor, J. [1 ]
Kamath, V. [1 ]
Whidden, C. [1 ]
Button, A. [1 ]
Button, J. [1 ]
Bruso, P. [1 ]
机构
[1] Multiple Sclerosis Ctr Northeastern New York, Latham, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:NP6 / NP8
页数:3
相关论文
共 50 条
  • [1] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis
    Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Susan
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
    Engel, Sinah
    Protopapa, Maria
    Steffen, Falk
    Papanastasiou, Vakis
    Nicolaou, Christoforos
    Protopapas, Michalis
    Zipp, Frauke
    Bittner, Stefan
    Luessi, Felix
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [3] Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet
    Oh, Unsong
    Woolbright, Emma
    Lehner-Gulotta, Diana
    Coleman, Rachael
    Conaway, Mark
    Goldman, Myla D.
    Brenton, J. Nicholas
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 73
  • [4] Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
    Bjornevik, Kjetil
    Munger, Kassandra L.
    Cortese, Marianna
    Barro, Christian
    Healy, Brian C.
    Niebuhr, David W.
    Scher, Ann I.
    Kuhle, Jens
    Ascherio, Alberto
    [J]. JAMA NEUROLOGY, 2020, 77 (01) : 58 - 64
  • [5] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [6] Serum Neurofilament Light Chain Levels Correlate with Disease Characteristics in Patients with Relapsing-Remitting Multiple Sclerosis from CARE-MS I
    Kuhle, Jens
    Daizadeh, Nadia
    Barro, Christian
    Michalak, Zuzanna
    Leppert, David
    Godin, Jean
    Shankara, Srinivas
    Samad, Tarek
    Jacobs, Alan
    Chung, Luke
    Roesch, Nora
    Kaiser, Carina
    Havari, Evis
    Kappos, Ludwig
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 30 - 30
  • [7] The Predictive Value of Neurofilament Light Chain Levels in Blood for Cognitive Impairment in Patients with Secondary Progressive Multiple Sclerosis
    Kuhle, Jens
    Kropshofer, Harald
    Barro, Christian
    Meinert, Rolf
    Haring, Dieter
    Leppert, David
    Dahlke, Frank
    Tomic, Davorka
    Kappos, Ludwig
    [J]. NEUROLOGY, 2019, 92 (15)
  • [8] Serum neurofilament light chain levels as multiple sclerosis biomarker
    Abd-ElHady, Mohamed E.
    Hashish, Ehab
    Yassine, Imane
    Anani, Maha
    Negm, Mohamed
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2024, 28 (02) : 28 - 32
  • [9] Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis
    Husseini, Leila
    Jung, Jakob
    Boess, Natalie
    Kruse, Niels
    Nessler, Stefan
    Stadelmann, Christine
    Metz, Imke
    Haupts, Michael
    Weber, Martin S.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [10] High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
    Buchmann, Arabella
    Pirpamer, Lukas
    Pinter, Daniela
    Voortman, Margarete
    Helmlinger, Birgit
    Pichler, Alexander
    Maceski, Aleksandra Maleska
    Benkert, Pascal
    Bachmaier, Gerhard
    Ropele, Stefan
    Reindl, Markus
    Leppert, David
    Kuhle, Jens
    Enzinger, Christian
    Khalil, Michael
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1389 - 1399